Alisa M Higgins, Lindsay R Berry, Elizabeth Lorenzi, Srinivas Murthy, Zoe McQuilten, Paul R Mouncey, Farah Al-Beidh, Djillali Annane, Yaseen M Arabi, Abi Beane, Wilma van Bentum-Puijk, Zahra Bhimani, Marc J M Bonten, Charlotte A Bradbury, Frank M Brunkhorst, Aidan Burrell, Adrian Buzgau, Meredith Buxton, Walton N Charles, Matthew Cove, Michelle A Detry, Lise J Estcourt, Elizabeth O Fagbodun, Mark Fitzgerald, Timothy D Girard, Ewan C Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, Christopher M Horvat, David T Huang, Nao Ichihara, Francois Lamontagne, John C Marshall, Daniel F McAuley, Anna McGlothlin, Shay P McGuinness, Bryan J McVerry, Matthew D Neal, Alistair D Nichol, Rachael L Parke, Jane C Parker, Karen Parry-Billings, Sam E C Peters, Luis F Reyes, Kathryn M Rowan, Hiroki Saito, Marlene S Santos, Christina T Saunders, Ary Serpa-Neto, Christopher W Seymour, Manu Shankar-Hari, Lucy M Stronach, Alexis F Turgeon, Anne M Turner, Frank L van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J Lewis, Derek C Angus, Colin J McArthur, Scott Berry, Lennie P G Derde, Anthony C Gordon, Steve A Webb, Patrick R Lawler
IMPORTANCE: The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown. OBJECTIVE: To determine the effect of multiple interventions for critically ill adults with COVID-19 on longer-term outcomes. DESIGN, SETTING, AND PARTICIPANTS: Prespecified secondary analysis of an ongoing adaptive platform trial (REMAP-CAP) testing interventions within multiple therapeutic domains in which 4869 critically ill adult patients with COVID-19 were enrolled between March 9, 2020, and June 22, 2021, from 197 sites in 14 countries...
January 3, 2023: JAMA